Effects of Intravenous Lidocaine on Quality of Recovery After Laparoscopic Bariatric Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Eduardo Cerchi BarbosaGuilherme H P C OrtegalJulia M AguirrePaola R R CostaLucas N FerreiraLaura F MoreiraGuilherme C SilvaPedro Paulo M Ferro FilhoDiogo M FerreiraPublished in: Obesity surgery (2024)
This systematic review and meta-analysis aimed to assess the effects of pre and intraoperative lidocaine infusion on short-term recovery quality after laparoscopic bariatric surgeries. In the search across MEDLINE, Embase, and Cochrane databases, we considered randomized controlled trials comparing intravenous lidocaine vs placebo (saline) for patients with obesity undergoing laparoscopic bariatric surgery. Seven studies (640 patients) were included. The lidocaine group had a significantly higher recovery quality score, a lower morphine consumption, and a notably reduced rate of nausea and vomiting compared with the placebo group. Additionally, Lidocaine infusion was associated with a shorter hospital stay, while no significant difference was observed in the time to bowel function recovery between both groups. In conclusion, lidocaine infusion before and during laparoscopic bariatric surgery contributes to an enhanced quality of recovery.
Keyphrases
- bariatric surgery
- weight loss
- robot assisted
- obese patients
- low dose
- randomized controlled trial
- quality improvement
- end stage renal disease
- healthcare
- type diabetes
- newly diagnosed
- ejection fraction
- metabolic syndrome
- high dose
- insulin resistance
- chronic kidney disease
- clinical trial
- systematic review
- emergency department
- patients undergoing
- body mass index
- minimally invasive
- artificial intelligence
- gastric bypass
- skeletal muscle
- deep learning
- patient reported outcomes
- open label
- big data
- case control
- patient reported